Saturday, November 07, 2020 11:48:34 AM
The NIH Video also talked about NDMA and cyclonite and actions to fight it. Rem is the SOC and new drugs need to be tested with it as a combo. Combinations of treatments and drugs are the future in the fight against COVID.
Vaccine talk was over my head but Trials and production for them will be important issues.
Minimal interactions and no long term safety issues were mentioned for Repurposed drugs' as past safety records will allow them to move to later Stage Trials and possible use quickly for specific indications.
Q? Are the sites where NP120 is being Trialed at using Rem as a SOC.?. One main concern brought up was will other drugs going to be conflicting with Rem which they are including as part of SOC?
US COVID cases raise to over 100K a day and world wide increases in infections are very concerning...GLTA...
PS...The NIH videocast will be reposted on their site soon so it can be watched again. It's 4 1/2 hrs long and I missed some. .
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM